case_images: PMC5112232_01
case_images: Insulin requirement evolution.
case_images: fped-04-00124-g001.jpg
case_images: PMC5112232_01_fped-04-00124-g001.jpg
case_images: F1
case_images: The baby continued to improve his nutritional status (median daily weight gain of 30 g) and got more and more glycemic stability while reducing insulin requirements (Figure 1).
case_images: Glycemic variations during intravenous insulin therapy.
case_images: fped-04-00124-g002.jpg
case_images: PMC5112232_01_fped-04-00124-g002.jpg
case_images: F2
case_images: Of course, we noted some glycemic excursions during the first days of intravenous insulin therapy (Figure 2), but after then, blood glucose variability decreased significantly, with almost all readings within the target range (100-250 mg/dl) (Figure 3).
case_images: Glycemic variations on CSII (the first 3 weeks).
case_images: fped-04-00124-g003.jpg
case_images: PMC5112232_01_fped-04-00124-g003.jpg
case_images: F3
case_images: Of course, we noted some glycemic excursions during the first days of intravenous insulin therapy (Figure 2), but after then, blood glucose variability decreased significantly, with almost all readings within the target range (100-250 mg/dl) (Figure 3).